LYRA - Lyra Therapeutics  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LYRA is currently covered by 5 analysts with an average price target of $30.94. This is a potential upside of $6.66 (27.43%) from yesterday's end of day stock price of $24.28.

Lyra Therapeutics 's activity chart (see below) currently has 4 price targets and 18 ratings on display. The stock rating distribution of LYRA is 66.67% BUY and 33.33% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 83.33% with an average time for these price targets to be met of 575.17 days.

Highest price target for LYRA is $2, Lowest price target is $2, average price target is $4.17.

Most recent stock forecast was given by MATTHEW CAUFIELD from HC WAINWRIGHT on 14-Mar-2025. First documented stock forecast 26-May-2020.

Best performing analysts who are covering LYRA - Lyra Therapeutics :

Jason Gerberry Matthew Caufield Robert Hazlett Louise Chen Dennis Ding Justin Zelin

Currently out of the existing stock ratings of LYRA, 10 are a BUY (66.67%), 5 are a HOLD (33.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$2

$-22.28 (-91.76%)

2 months 24 days ago
(14-Mar-2025)

5/5 (100%)

$1.83 (1076.47%)

422

Buy

9 months 23 days ago
(15-Aug-2024)

1/1 (100%)

$9 (150.00%)

1105

Hold

$0.5

$-23.78 (-97.94%)

1 years 1 months ago
(07-May-2024)

1/1 (100%)

$0.08 (19.05%)

386

Hold

$15

1 years 1 months 1 days ago
(06-May-2024)

1/1 (100%)

$11.36 (312.09%)

605

Buy

$10

$-14.28 (-58.81%)

$11

1 years 1 months 5 days ago
(02-May-2024)

6/6 (100%)

$5.37 (115.98%)

933

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LYRA (Lyra Therapeutics ) average time for price targets to be met?

On average it took 575.17 days on average for the stock forecasts to be realized with a an average price target met ratio 83.33

Which analyst has the current highest performing score on LYRA (Lyra Therapeutics ) with a proven track record?

JASON GERBERRY

Which analyst has the current lower performing score on LYRA (Lyra Therapeutics ) with a proven track record?

JUSTIN ZELIN

Which analyst has the most public recommendations on LYRA (Lyra Therapeutics )?

Jason Gerberry works at BAML and has 5 price targets and 3 ratings on LYRA

Which analyst is the currently most bullish on LYRA (Lyra Therapeutics )?

Justin Zelin with highest potential upside - $0

Which analyst is the currently most reserved on LYRA (Lyra Therapeutics )?

Dennis Ding with lowest potential downside - -$23.78

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?